597 related articles for article (PubMed ID: 33505021)
1. A growth-factor-activated lysosomal K
Wie J; Liu Z; Song H; Tropea TF; Yang L; Wang H; Liang Y; Cang C; Aranda K; Lohmann J; Yang J; Lu B; Chen-Plotkin AS; Luk KC; Ren D
Nature; 2021 Mar; 591(7850):431-437. PubMed ID: 33505021
[TBL] [Abstract][Full Text] [Related]
2. TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation.
Jinn S; Drolet RE; Cramer PE; Wong AH; Toolan DM; Gretzula CA; Voleti B; Vassileva G; Disa J; Tadin-Strapps M; Stone DJ
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2389-2394. PubMed ID: 28193887
[TBL] [Abstract][Full Text] [Related]
3. Lysosomal K
Qu L; Lin B; Zeng W; Fan C; Wu H; Ge Y; Li Q; Li C; Wei Y; Xin J; Wang X; Liu D; Cang C
EMBO Rep; 2022 Sep; 23(9):e53234. PubMed ID: 35913019
[TBL] [Abstract][Full Text] [Related]
4. Transmembrane Protein 175, a Lysosomal Ion Channel Related to Parkinson's Disease.
Tang T; Jian B; Liu Z
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238672
[TBL] [Abstract][Full Text] [Related]
5. Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease.
Jinn S; Blauwendraat C; Toolan D; Gretzula CA; Drolet RE; Smith S; Nalls MA; Marcus J; Singleton AB; Stone DJ
Hum Mol Genet; 2019 Oct; 28(19):3244-3254. PubMed ID: 31261387
[TBL] [Abstract][Full Text] [Related]
6. Common and Rare Variants in TMEM175 Gene Concur to the Pathogenesis of Parkinson's Disease in Italian Patients.
Palomba NP; Fortunato G; Pepe G; Modugno N; Pietracupa S; Damiano I; Mascio G; Carrillo F; Di Giovannantonio LG; Ianiro L; Martinello K; Volpato V; Desiato V; Acri R; Storto M; Nicoletti F; Webber C; Simeone A; Fucile S; Maglione V; Esposito T
Mol Neurobiol; 2023 Apr; 60(4):2150-2173. PubMed ID: 36609826
[TBL] [Abstract][Full Text] [Related]
7. Translocation of TMEM175 Lysosomal Potassium Channel to the Plasma Membrane by Dynasore Compounds.
Pergel E; Veres I; Csigi GI; Czirják G
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638858
[TBL] [Abstract][Full Text] [Related]
8. TMEM175 Is an Organelle K(+) Channel Regulating Lysosomal Function.
Cang C; Aranda K; Seo YJ; Gasnier B; Ren D
Cell; 2015 Aug; 162(5):1101-12. PubMed ID: 26317472
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes.
Hu M; Li P; Wang C; Feng X; Geng Q; Chen W; Marthi M; Zhang W; Gao C; Reid W; Swanson J; Du W; Hume RI; Xu H
Cell; 2022 Jun; 185(13):2292-2308.e20. PubMed ID: 35750034
[TBL] [Abstract][Full Text] [Related]
10. TMEM175 mediates Lysosomal function and participates in neuronal injury induced by cerebral ischemia-reperfusion.
Zhang M; Lu H; Xie X; Shen H; Li X; Zhang Y; Wu J; Ni J; Li H; Chen G
Mol Brain; 2020 Aug; 13(1):113. PubMed ID: 32799888
[TBL] [Abstract][Full Text] [Related]
11. Gating and selectivity mechanisms for the lysosomal K
Oh S; Paknejad N; Hite RK
Elife; 2020 Mar; 9():. PubMed ID: 32228865
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal LAMP proteins regulate lysosomal pH by direct inhibition of the TMEM175 channel.
Zhang J; Zeng W; Han Y; Lee WR; Liou J; Jiang Y
Mol Cell; 2023 Jul; 83(14):2524-2539.e7. PubMed ID: 37390818
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease risk protein TMEM175 keeps lysosomes running on a proton leak.
Perdigoto CN
Nat Struct Mol Biol; 2022 Jul; 29(7):626. PubMed ID: 35821258
[No Abstract] [Full Text] [Related]
14. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of 4-aminopyridine inhibition of the lysosomal channel TMEM175.
Oh S; Stix R; Zhou W; Faraldo-Gómez JD; Hite RK
Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2208882119. PubMed ID: 36279431
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
[TBL] [Abstract][Full Text] [Related]
17. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
[TBL] [Abstract][Full Text] [Related]
18. Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.
Martin S; Smolders S; Van den Haute C; Heeman B; van Veen S; Crosiers D; Beletchi I; Verstraeten A; Gossye H; Gelders G; Pals P; Hamouda NN; Engelborghs S; Martin JJ; Eggermont J; De Deyn PP; Cras P; Baekelandt V; Vangheluwe P; Van Broeckhoven C;
Acta Neuropathol; 2020 Jun; 139(6):1001-1024. PubMed ID: 32172343
[TBL] [Abstract][Full Text] [Related]
19. Increased Lysosomal Exocytosis Induced by Lysosomal Ca
Tsunemi T; Perez-Rosello T; Ishiguro Y; Yoroisaka A; Jeon S; Hamada K; Rammonhan M; Wong YC; Xie Z; Akamatsu W; Mazzulli JR; Surmeier DJ; Hattori N; Krainc D
J Neurosci; 2019 Jul; 39(29):5760-5772. PubMed ID: 31097622
[TBL] [Abstract][Full Text] [Related]
20. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
